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A middle-aged man presented to the emergency 
department with a three-day history of macroscopic 
haematuria and mild discomfort on his right lower 
back. He denied fever or other urinary complaints. His 
past medical history was significant for chronic low 
back pain, benign prostatic hyperplasia, and obesity, 
for which a bariatric surgery was performed 21 years 
earlier. In face of the clinical suspicion of nephrolithi-
asis, a computed tomography scan of the abdomen 
was ordered, confirming the hypothesis by showing 
nonobstructive micro calculi on the lower pole of the 
right kidney. 
Surprisingly, though, multiple bilateral subcuta-
neous calcifications were seen on the gluteal region 
(Fig. 1). When questioned, the patient affirmed having 
received intragluteal injections of non-steroidal anti-in-
flammatory drugs (NSAIDs) and corticosteroids multiple 
times in the past for his low back pain. 
A diagnosis of injection site granuloma was made. 
There is no data on the literature about the prevalence 
of subcutaneous calcification on the gluteal region 
secondary to inadvertent injection of an intramuscular 
drug on the fat tissue, with reports having been pub-
lished about granuloma formation after administration 
of several medications, such as opiates, NSAIDs [1], 
leuprorelin [2] and Sandostatin [3].
However, given that about half of the intended 
intramuscular injections are mistakenly applied sub-
cutaneously [4], injection site granuloma may not be 
a highly uncommon entity. Its importance resides on 
the possible differential diagnosis with more severe con-
Figure 1. Axial scan of CT of abdomen evidencing well-
demarcated lesions on the subcutaneous fat tissue, either 
fully or rim calcified
ditions, such as soft-tissue sarcoma, dermatomyositis 
and systemic sclerosis.
Bilaterality and lesion stability over time speaks 
against malignancy. The absence of muscle weakness 
or typical skin lesions makes dermatomyositis quite 
unlikely. For systemic sclerosis, one would expect an 
antecedent of the Raynaud phenomenon, sclerodactyly 
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and digital ulcers. Heterotopic ossification usually has an 
identifiable trigger event, such as a history of trauma or 
joint replacement surgery. Accurate history taking may 
lead to the final diagnosis, obviating further workup [5]. 
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